Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sagami Chemical Industry is a Japanese contract development and manufacturing organization (CDMO) that specializes in the production of active pharmaceutical ingredients (APIs) and advanced intermediates. Established in 1954, the company provides a wide range of services including custom synthesis, process development, and commercial-scale manufacturing under strict GMP standards. They are particularly noted for their expertise in handling complex organic synthesis and high-potency active pharmaceutical ingredients (HPAPIs). With a focus on small molecule modalities, Sagami Chemical Industry supports global pharmaceutical partners from the early stages of drug development through to commercialization. Their facilities are equipped to manage specialized chemical reactions, ensuring high-quality output for diverse therapeutic applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sagami Chemical Industry.